Company news

Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class A (SZSE:002773) news

Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class A news releases on 6ix. Latest, Apr 22, 2026: Chengdu Kanghong Pharmaceutical Q1 Net Profit Down 23.1% Y/Y

View Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class A →

Press releases & updates

Chengdu Kanghong Pharmaceutical Q1 Net Profit Down 23.1% Y/Y

April 22, 2026

Chengdu Kanghong: US FDA Approves KHN921 Clinical Trial For Hypertrophic Cardiomyopathy Treatment

April 19, 2026